Search Results - "Eclov RJ"

α-Helical peptides: design strategies and recent advances in biomedical applications.

Authors: Yin M Ding F Luo G et al.

Source: Journal of translational medicine [J Transl Med] 2026 Apr 20; Vol. 24 (1). Date of Electronic Publication: 2026 Apr 20.

Publication Type: Journal Article; Review

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE

Longitudinal multi-omics analyses of chemotherapy-induced peripheral neuropathy in response to taxanes.

Authors: Sharma, Anukriti Johnson, Ken B. Sen, Alper et al.

Source: BMC Cancer. 10/15/2025, Vol. 25 Issue 1, p1-16. 16p.

EPHA5 and SOD2 genetic variants and their link to neurofilament light chain: early detection of taxane-induced neurotoxicity in Egyptian breast cancer patients.

Authors: Kassem, Amira B. Ahmed, Amira Abdelmonem El‑Bassiouny, Noha A. et al.

Source: Future Journal of Pharmaceutical Sciences. 6/20/2025, Vol. 11 Issue 1, p1-13. 13p.

Genetic determinants of paclitaxel-induced peripheral neuropathy: a review of current literature.

Authors: Sivadas, Swathi Krishna Das, Aiswarya Vijayakumar, Nandana et al.

Source: Drug Metabolism Reviews. May2025, Vol. 57 Issue 2, p190-207. 18p.

SNP's use as a potential chemotoxicity stratification tool in breast cancer: from bench to clinic.

Authors: Moustafa HAM El-Dakroury WA Ashraf A et al.

Source: Functional & integrative genomics [Funct Integr Genomics] 2025 Apr 22; Vol. 25 (1), pp. 93. Date of Electronic Publication: 2025 Apr 22.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Country of Publication: Germany NLM ID: 100939343 Publication Model: Electronic Cited Medium: Internet ISSN: 1438-7948 (Electronic) Linking ISSN: 1438793X NLM ISO Abbreviation: Funct Integr Genomics Subsets: MEDLINE

Prevention of paclitaxel-induced peripheral neuropathy: literature review of potential pharmacological interventions.

Authors: Mahmoud, Aalaa Mahmoud Ahmed Shawqi El Said, Nouran Omar Shash, Emad et al.

Source: Future Journal of Pharmaceutical Sciences. 6/5/2024, Vol. 10 Issue 1, p1-15. 15p.

Pseudokinase TRIB3 stabilizes SSRP1 via USP10-mediated deubiquitination to promote multiple myeloma progression.

Authors: Wang H Liang L Xie Y et al.

Source: Oncogene [Oncogene] 2025 Mar; Vol. 44 (10), pp. 694-708. Date of Electronic Publication: 2024 Dec 09.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE

Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes.

Authors: Park, Susanna B. Kwok, John B. Loy, Clement T. et al.

Source: BMC Cancer. 2014, Vol. 14 Issue 1, p1-11. 11p.

Comprehensive breast cancer risk analysis with whole exome sequencing and the prevalence of BRCA1 and ABCG2 mutations and oncogenic HPV.

Authors: Bumrungthai, Sureewan Duangjit, Sureewan Passorn, Supaporn et al.

Source: Biomedical Reports. Oct2024, Vol. 21 Issue 4, pN.PAG-N.PAG. 1p.

Chemotherapy-induced peripheral neuropathy: evidence from genome-wide association studies and replication within multiple myeloma patients.

Authors: Mahmoudpour, Seyed Hamidreza Bandapalli, Obul Reddy Campo, Chiara et al.

Source: BMC Cancer. 8/15/2018, Vol. 18 Issue 1, p1-9. 9p. 1 Diagram, 4 Charts.

Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.

Authors: Schneider, B P Li, L Shen, F et al.

Source: British Journal of Cancer. 9/9/2014, Vol. 111 Issue 6, p1241-1248. 8p. 2 Diagrams, 2 Charts, 2 Graphs.

Randomised phase II study comparing dose-escalated weekly paclitaxel vs standard-dose weekly paclitaxel for patients with previously treated advanced gastric cancer.

Authors: Shitara, K Yuki, S Tahahari, D et al.

Source: British Journal of Cancer. 1/21/2014, Vol. 110 Issue 2, p271-277. 7p.

Genome-wide association study of sensory disturbances in the inferior alveolar nerve after bilateral sagittal split ramus osteotomy.

Authors: Daisuke Kobayashi Daisuke Nishizawa Yoshito Takasaki et al.

Source: Molecular Pain. 2013, Vol. 9 Issue 1, p1-16. 16p. 1 Black and White Photograph, 1 Diagram, 6 Charts, 2 Graphs.

Regulatory T cell dysfunction and exhaustion in uveitis: immunometabolic mechanisms, microenvironmental drivers, and emerging therapeutic strategies.

Authors: Su X Tan Q Zheng L et al.

Source: Frontiers in immunology [Front Immunol] 2026 May 05; Vol. 17, pp. 1793865. Date of Electronic Publication: 2026 May 05 (Print Publication: 2026).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Lanatoside C activates the E3 ligase STUB1 to inhibit FOXP3 transcriptional activity and promote antitumor immunity.

Authors: Zhou Q Yang T Yu X et al.

Source: EMBO molecular medicine [EMBO Mol Med] 2025 Mar; Vol. 17 (3), pp. 563-588. Date of Electronic Publication: 2025 Feb 20.

Publication Type: Journal Article

Journal Info: Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE

Future Directions in the Management of Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.

Authors: Sarafoglou K Auchus RJ

Source: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2025 Jan 21; Vol. 110 (Supplement_1), pp. S74-S87.

Publication Type: Journal Article; Review

Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE

Advances in Foxp3+ regulatory T cells (Foxp3+ Treg) and key factors in digestive malignancies.

Authors: Wang W Ding M Wang Q et al.

Source: Frontiers in immunology [Front Immunol] 2024 Jun 11; Vol. 15, pp. 1404974. Date of Electronic Publication: 2024 Jun 11 (Print Publication: 2024).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Evolution of predictive risk factor analysis for chemotherapy-related toxicity.

Authors: Hertz DL Lustberg MB Sonis S

Source: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2023 Sep 29; Vol. 31 (10), pp. 601. Date of Electronic Publication: 2023 Sep 29.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE

Novel treatments for congenital adrenal hyperplasia.

Authors: Schröder MAM Claahsen-van der Grinten HL

Source: Reviews in endocrine & metabolic disorders [Rev Endocr Metab Disord] 2022 Jun; Vol. 23 (3), pp. 631-645. Date of Electronic Publication: 2022 Feb 23.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Country of Publication: Germany NLM ID: 100940588 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2606 (Electronic) Linking ISSN: 13899155 NLM ISO Abbreviation: Rev Endocr Metab Disord Subsets: MEDLINE

A dynamic portrait of adverse events for breast cancer patients: results from a phase II clinical trial of eribulin in advanced HER2-negative breast cancer.

Authors: Filho OM Giobbie-Hurder A Lin NU et al.

Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2021 Jan; Vol. 185 (1), pp. 135-144. Date of Electronic Publication: 2020 Oct 06.

Publication Type: Clinical Trial, Phase II; Journal Article

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE